Literature DB >> 28197713

Early vascular responses after everolimus-eluting stent implantation assessed by serial observations of intracoronary optical coherence tomography.

Hideki Yano1,2, Shigeo Horinaka3, Mayuko Ishikawa4,3, Toshihiko Ishimitsu3.   

Abstract

A recent OCT study revealed that the lack of stent strut endothelial coverage is associated with late stent thrombosis after drug-eluting stent implantation. However, the sequential changes of stent strut endothelial coverage in the extremely early period have never been reported. Serial OCTs were performed in 35 patients with 35 EES (everolimus-eluting stent)-treated de novo lesions at 0, 2, 4, and 12 weeks after EES implantation. Serial changes in quantitative parameters of the neointima (neointimal thickness, stent strut coverage, and apposition of each strut) were analyzed. Mean neointimal thickness significantly increased from 35.9 to 51.8 and 108.2 μm at 2, 4, and 12 weeks, respectively (p < 0.001 for all), and the percentage of uncovered stent struts significantly decreased from 74.7 to 19.5% and 0.4% (p < 0.001, respectively). There was no stent malapposition at 4 weeks compared with immediate post-intervention (0 vs. 5.4 %, p = 0.031). This OCT study demonstrates that neointimal coverage of stent struts progresses to about 80 % and malapposition of stent struts completely disappears at 4 weeks after EES implantation. In addition, neointimal coverage of stent struts was almost complete within 12 weeks.

Entities:  

Keywords:  Apposition; Everolimus-eluting stent; Neointimal thickness; Optical coherence tomography; Stent strut coverage

Mesh:

Substances:

Year:  2017        PMID: 28197713     DOI: 10.1007/s00380-016-0940-9

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  35 in total

1.  Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition.

Authors:  Jun Tanigawa; Peter Barlis; Carlo Di Mario
Journal:  EuroIntervention       Date:  2007-05       Impact factor: 6.534

2.  Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach.

Authors:  N Gonzalo; P W Serruys; T Okamura; Z J Shen; Y Onuma; H M Garcia-Garcia; G Sarno; C Schultz; R J van Geuns; J Ligthart; E Regar
Journal:  Heart       Date:  2009-08-10       Impact factor: 5.994

3.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

Authors:  Michael Joner; Aloke V Finn; Andrew Farb; Erik K Mont; Frank D Kolodgie; Elena Ladich; Robert Kutys; Kristi Skorija; Herman K Gold; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2006-05-05       Impact factor: 24.094

4.  Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.

Authors:  Fausto Feres; Ricardo A Costa; Alexandre Abizaid; Martin B Leon; J Antônio Marin-Neto; Roberto V Botelho; Spencer B King; Manuela Negoita; Minglei Liu; J Eduardo T de Paula; José A Mangione; George X Meireles; Hélio J Castello; Eduardo L Nicolela; Marco A Perin; Fernando S Devito; André Labrunie; Décio Salvadori; Marcos Gusmão; Rodolfo Staico; J Ribamar Costa; Juliana P de Castro; Andrea S Abizaid; Deepak L Bhatt
Journal:  JAMA       Date:  2013-12-18       Impact factor: 56.272

5.  A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation).

Authors:  Byeong-Keuk Kim; Myeong-Ki Hong; Dong-Ho Shin; Chung-Mo Nam; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Tae-Soo Kang; Byoung-Eun Park; Woong-Chol Kang; Seung-Hwan Lee; Jung-Han Yoon; Bum-Kee Hong; Hyuck-Moon Kwon; Yangsoo Jang
Journal:  J Am Coll Cardiol       Date:  2012-09-19       Impact factor: 24.094

6.  Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET).

Authors:  Takeshi Kimura; Takeshi Morimoto; Masahiro Natsuaki; Hiroki Shiomi; Keiichi Igarashi; Kazushige Kadota; Kengo Tanabe; Yoshihiro Morino; Takashi Akasaka; Yoshiki Takatsu; Hideo Nishikawa; Yoshito Yamamoto; Yoshihisa Nakagawa; Yasuhiko Hayashi; Masashi Iwabuchi; Hisashi Umeda; Kazuya Kawai; Hisayuki Okada; Kazuo Kimura; Charles A Simonton; Ken Kozuma
Journal:  Circulation       Date:  2012-07-23       Impact factor: 29.690

7.  Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study.

Authors:  Takashi Kubo; Toshio Imanishi; Hironori Kitabata; Akio Kuroi; Satoshi Ueno; Takashi Yamano; Takashi Tanimoto; Yoshiki Matsuo; Takashi Masho; Shigeho Takarada; Atsushi Tanaka; Nobuo Nakamura; Masato Mizukoshi; Yoshiaki Tomobuchi; Takashi Akasaka
Journal:  JACC Cardiovasc Imaging       Date:  2008-07

8.  Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography.

Authors:  Hiroki Katoh; Junya Shite; Toshiro Shinke; Daisuke Matsumoto; Yusuke Tanino; Daisuke Ogasawara; Takahiro Sawada; Naoki Miyoshi; Hiroyuki Kawamori; Naoki Yoshino; Ken-ichi Hirata
Journal:  Circ J       Date:  2009-04-14       Impact factor: 2.993

9.  Endothelial cell recovery between comparator polymer-based drug-eluting stents.

Authors:  Michael Joner; Gaku Nakazawa; Aloke V Finn; Shawn Chin Quee; Leslie Coleman; Eduardo Acampado; Patricia S Wilson; Kristi Skorija; Qi Cheng; Xin Xu; Herman K Gold; Frank D Kolodgie; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2008-07-29       Impact factor: 24.094

Review 10.  Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V).

Authors:  Imad Sheiban; Gianluca Villata; Mario Bollati; Dario Sillano; Marzia Lotrionte; Giuseppe Biondi-Zoccai
Journal:  Vasc Health Risk Manag       Date:  2008
View more
  4 in total

1.  Comparison of the vessel healing process after everolimus-eluting stent and bare metal stent implantations in patients with ST-elevation myocardial infarction.

Authors:  Hideki Yano; Shigeo Horinaka; Manami Watahik; Tomoko Watanabe; Toshihiko Ishimitsu
Journal:  Heart Vessels       Date:  2018-11-03       Impact factor: 2.037

2.  Bioresorbable vascular scaffolds in coronary chronic total occlusions revascularization: safety assessment related to struts coverage and apposition in 6-month OCT follow-up.

Authors:  Rosa Alba Abellas-Sequeiros; Raymundo Ocaranza-Sanchez; Ramiro Trillo-Nouche; Carlos Gonzalez-Juanatey; Jose Ramon Gonzalez-Juanatey
Journal:  Heart Vessels       Date:  2017-04-21       Impact factor: 2.037

3.  Angioscopic imaging one month after the implantation of a drug-eluting stent following drug-coated balloon treatment.

Authors:  Hiromoto Sone; Hiroyoshi Mori; Tokutada Sato; Yosuke Takei; Kazuma Tashiro; Masahiro Sasai; Hiroshi Suzuki
Journal:  Int J Cardiol Heart Vasc       Date:  2018-11-06

Review 4.  Endpoint selection for noninferiority percutaneous coronary intervention trials: a methodological description.

Authors:  Matthias Waliszewski; Mark Rosenberg; Harald Rittger; Viktor Breul; Florian Krackhardt
Journal:  Ther Adv Cardiovasc Dis       Date:  2020 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.